Stocks
ALX Oncology Holdings (ALXO) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 4.35 | 2.08 | 1.05 | 0.84 | 0.40 | 1.53 | |||
| Changes by years, y/y, % | -56% | -52% | -50% | -20% | -52% | -47.5% | |||
ALX Oncology Holdings. Debt/EBITDA
ALX Oncology Holdings. Debt/EBITDA, changes, %
ALX Oncology Holdings (ALXO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.69 | 0.55 | 0.53 | 0.40 | 1.53 | 1.53 | ||
| Changes by years, y/y, % | -20% | -33% | -43% | -55% | +123% | |||
| Changes by quarters, q/q, % | -23% | -20% | -4% | -25% | +285% | |||
